Atlas Trials

Cerus Corporation

17 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cerus Corporation

RecordFirmDate
Cryo-FIRST: Effectiveness of INTERCEPT Fibrinogen Complex (IFC) for Trauma-Associated Hemorrhage (NCT07218185)Cerus Corporation2026-07-01
Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs (NCT07152379)Cerus Corporation2026-06-01
Biotin-Acridine Red Cell Exchange Kinetics (NCT07155031)Cerus Corporation2025-10-15
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1 (NCT07015437)Cerus Corporation2025-09-19
In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days (NCT04022889)Cerus Corporation2019-11-05
Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients (NCT03459287)Cerus Corporation2018-12-05

Track Cerus Corporation automatically

Every clearance here is in the API, with alerts when new ones post.